Ionizer™ Technology: It’s Simple, All You Need Is Air™
Unlimited, On-Demand Nitric Oxide From Hospital to Home


- Hospital NICU setting
- Low-concentration inhaled nitric oxide (iNO): ≤80 ppm
- To treat term and near-term neonates with hypoxic respiratory failure, commonly referred to as persistent pulmonary hypertension of the newborn (PPHN)
- No cylinders. No hassle.

- Hospital setting
- High-concentration iNO: 80 to 400 ppm
- To treat community-acquired viral pneumonia (including COVID-19) and bronchiolitis
- No cylinders

- At-home treatment
- High-concentration iNO: 80 to 400 ppm
- To treat nontuberculous mycobacteria (NTM) and lung infections in patients with underlying chronic obstructive pulmonary disease (COPD)
- No cylinders
LungFit: A Family of Products for Flexibility in iNO Dosing
Download Spec Chart | |
|
|
---|---|---|---|
Use location | Hospital NICU setting | Hospital setting | At-home treatment |
For treatment of | Term and near-term neonates with hypoxic respiratory failure, commonly referred to as persistent pulmonary hypertension of the newborn (PPHN) | Community-acquired viral pneumonia (including COVID-19) and bronchiolitis | Nontuberculous mycobacteria (NTM) lung infection and in patients with underlying chronic obstructive pulmonary disease (COPD), suffering from persistent lung infections |
iNO concentration | Low-concentration iNO: ≤80 ppm | High-concentration iNO: 80 to 400 ppm | High-concentration iNO: 80 to 400 ppm |
Supplemental oxygen can be utilized through the system |
|
|
– |
Alarms to monitor performance |
|
|
|
Disposable NO2 Smart Filters |
|
|
|
System weight | ~44 lb | ~20 lb | ~18 lb |
Usable with standard 110V or 220V electric outlets |
|
|
|
Visit Product Page | See Active Pipeline |
A Future Built on a Legacy of Innovation
The LungFit family of products are designed by the same inventors who developed the first nitric oxide delivery system and other systems in use worldwide.*
The Benefits of the First-in-Class LungFit Technology
-
Transforms iNO treatment with simplicity and certainty to provide effective and efficient patient care
-
Improves operating economics for the hospital by avoiding cost and logistics associated with 45-lb high-pressure cylinder iNO treatment
-
Reduces burdensome training, inventory, and storage requirements by eliminating the need for iNO cylinders
-
Convenient storage of small NO2 Smart Filters and disposable accessories at the point of care
-
Enables integration of iNO management into hospital point-of-use solutions for streamlined logistics
-
Reduces risk of NO2 exposure to patient and clinician with NO2 Smart Filter and integrated autopurging1
Product News and Investor
Relations Announcements
Revolutionizing Nitric
Oxide Therapy
Reference: 1. Rimkus M, Montgomery F, Bathe D. On-demand nitric oxide for ventilator-based nitric oxide inhalation: a risk-reduction perspective. Abstract presented at: 22nd Congress of the International Society for Aerosols in Medicine (ISAM); May 24, 2019; Montreux, Switzerland. Accessed May 13, 2022.
*The inventors of the LungFit Systems are also listed as inventors on the patents for the following nitric oxide delivery systems: INOvent, INOmax DSIR, INOmax DSIR Plus, INOmax DSIR Plus MRI.
Caution: LungFit®PRO and LungFit®GO are investigational devices, limited by federal (or United States) law to investigational use.